Does GEMTUZUMAB OZOGAMICIN Cause Neoplasm progression? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Neoplasm progression have been filed in association with GEMTUZUMAB OZOGAMICIN (Mylotarg). This represents 3.2% of all adverse event reports for GEMTUZUMAB OZOGAMICIN.
58
Reports of Neoplasm progression with GEMTUZUMAB OZOGAMICIN
3.2%
of all GEMTUZUMAB OZOGAMICIN reports
31
Deaths
14
Hospitalizations
How Dangerous Is Neoplasm progression From GEMTUZUMAB OZOGAMICIN?
Of the 58 reports, 31 (53.4%) resulted in death, 14 (24.1%) required hospitalization, and 10 (17.2%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMTUZUMAB OZOGAMICIN. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does GEMTUZUMAB OZOGAMICIN Cause?
Febrile neutropenia (412)
Pyrexia (138)
Sepsis (122)
Thrombocytopenia (117)
Venoocclusive liver disease (117)
Off label use (88)
Drug ineffective (87)
Death (81)
Bone marrow failure (80)
Neutropenia (68)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which GEMTUZUMAB OZOGAMICIN Alternatives Have Lower Neoplasm progression Risk?
GEMTUZUMAB OZOGAMICIN vs GEMZAR
GEMTUZUMAB OZOGAMICIN vs GENTAMICIN
GEMTUZUMAB OZOGAMICIN vs GEODON
GEMTUZUMAB OZOGAMICIN vs GILENYA
GEMTUZUMAB OZOGAMICIN vs GILOTRIF